Literature DB >> 3485661

Metastatic thymoma: a case report and immunohistological analysis.

D M Salter, A S Krajewski.   

Abstract

A patient with metastatic lymphocyte predominant thymoma was studied and an immunohistological analysis of frozen and paraffin sections was performed. The immunophenotype of the lymphoid cells was similar to that of primary thymomas and T cell lymphoblastic lymphomas. The epithelial cells reacted with an anticytokeratin monoclonal antibody. The results have diagnostic implications for the histopathologist using immunohistochemistry as a diagnostic aid and it is concluded that a panel of monoclonal antibodies against both lymphoid and epithelial markers should be used for immunohistological typing of tumours of uncertain histogenesis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3485661      PMCID: PMC499762          DOI: 10.1136/jcp.39.3.275

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  11 in total

1.  Epithelial membrane antigen and lymphoid cells.

Authors: 
Journal:  Lancet       Date:  1985-01-12       Impact factor: 79.321

2.  Phenotypic heterogeneity and cellular origins of T cell malignancies.

Authors:  M F Greaves; J Rao; G Hariri; W Verbi; D Catovsky; P Kung; G Goldstein
Journal:  Leuk Res       Date:  1981       Impact factor: 3.156

3.  Expression of leucocyte common antigen and epithelial membrane antigen in plasmacytic malignancies.

Authors:  D M Salter; A S Krajewski; E P Miller; A E Dewar
Journal:  J Clin Pathol       Date:  1985-07       Impact factor: 3.411

Review 4.  Immunohistological analysis of human lymphoma: correlation of histological and immunological categories.

Authors:  H Stein; K Lennert; A C Feller; D Y Mason
Journal:  Adv Cancer Res       Date:  1984       Impact factor: 6.242

5.  Immunohistology of human thymomas.

Authors:  M J Kornstein; J A Hoxie; A I Levinson; J J Brooks
Journal:  Arch Pathol Lab Med       Date:  1985-05       Impact factor: 5.534

6.  Clinical importance of analysing malignant tumours of uncertain origin with immunohistological techniques.

Authors:  K C Gatter; C Alcock; A Heryet; D Y Mason
Journal:  Lancet       Date:  1985-06-08       Impact factor: 79.321

7.  The use of antikeratin antiserum as a diagnostic tool: thymoma versus lymphoma.

Authors:  H Battifora; T T Sun; R M Bahu; S Rao
Journal:  Hum Pathol       Date:  1980-11       Impact factor: 3.466

8.  Detection by S-100 immunolabelling of interdigitating reticulum cells in human thymomas.

Authors:  L Lauriola; F Michetti; V M Stolfi; G Tallini; D Cocchia
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1984

9.  Thymoma: lymphoid and epithelial components mirror the phenotype of normal thymus.

Authors:  N Mokhtar; S M Hsu; R P Lad; B F Haynes; E S Jaffe
Journal:  Hum Pathol       Date:  1984-04       Impact factor: 3.466

10.  Human thymoma: immunologic characteristics of the lymphocytic component.

Authors:  L Lauriola; N Maggiano; M Marino; A Carbone; M Piantelli; P Musiani
Journal:  Cancer       Date:  1981-11-01       Impact factor: 6.860

View more
  4 in total

1.  Immunohistochemical study of 22 cases of thymoma.

Authors:  D Lee; D H Wright
Journal:  J Clin Pathol       Date:  1988-12       Impact factor: 3.411

2.  A spectrum of thymomas over a three year period.

Authors:  M Bolster; W Kealy
Journal:  Ir J Med Sci       Date:  1988-11       Impact factor: 1.568

3.  Hepatic metastasis of thymoma: case report and immunohistochemical study.

Authors:  Daniela Speisky; María Teresa García de Davila; Felix Vigovich; Julian Mendez; Rafael Maurette; Marcos García Ejarque; Juan Carlos Spina; Alejandro Iotti; Pablo Dezanzo
Journal:  Ecancermedicalscience       Date:  2016-11-22

4.  Diagnostic features and subtyping of thymoma lymph node metastases.

Authors:  Stefano Sioletic; Libero Lauriola; Enzo Gallo; Robert Martucci; Amelia Evoli; Giovannella Palmieri; Enrico Melis; Giuseppe Pizzi; Massimo Rinaldi; Maurizio Lalle; Edoardo Pescarmona; Pierluigi Granone; Francesco Facciolo; Mirella Marino
Journal:  Biomed Res Int       Date:  2014-07-08       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.